Healthcare provider profile · identity verified

Emmanuel V Rivera, MD

Allopathic & Osteopathic Physicians|Family Medicine|Geriatric Medicine · CINCINNATI, OH · NPI 1912946146

Profile state: payments and partd Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

CMS Open Payments records show Emmanuel V Rivera, MD received $140.77 in general payments during 2025 across 2 reported records.

GlaxoSmithKline, LLC. accounted for 86.2% of that reported general-payment amount.

The Open Payments records used for this analysis explicitly named 2 associated products.

A separate comparison found the same explicitly named product in public Medicare Part D data: Rexulti.

GlaxoSmithKline, LLC. reported payments to this doctor in 2025. Across the 2025 Open Payments General Payment records loaded for this analysis, that same reporting entity reported AREXVY as an associated drug or biological on 47563 records involving 28786 distinct recipient NPIs. Public Medicare Part D data also shows 24 claims for Arexvy by this doctor in 2024.

GlaxoSmithKline, LLC. reported payments to this doctor in 2025. Across the 2025 Open Payments General Payment records loaded for this analysis, that same reporting entity reported TRELEGY ELLIPTA as an associated drug or biological on 131532 records involving 37148 distinct recipient NPIs. Public Medicare Part D data also shows 28 claims for Trelegy Ellipta by this doctor in 2024.

Otsuka America Pharmaceutical, Inc. reported payments to this doctor in 2025. Across the 2025 Open Payments General Payment records loaded for this analysis, that same reporting entity reported NUEDEXTA as an associated drug or biological on 393 records involving 285 distinct recipient NPIs. Public Medicare Part D data also shows 50 claims for Nuedexta by this doctor in 2024.

Otsuka America Pharmaceutical, Inc. reported payments to this doctor in 2025. Across the 2025 Open Payments General Payment records loaded for this analysis, that same reporting entity reported REXULTI as an associated drug or biological on 160756 records involving 46288 distinct recipient NPIs. Public Medicare Part D data also shows 21 claims for Rexulti by this doctor in 2024.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

$140.77

2 reported records · 2 companies

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Who paid this doctor?

Companies in 2025 General Payments

Reported company	Canonical company	Amount	Share	Records	Year
GlaxoSmithKline, LLC.	Unresolved — no canonical attribution shown	$121.27	86.2%	1	2025
Otsuka America Pharmaceutical, Inc.	Unresolved — no canonical attribution shown	$19.50	13.8%	1	2025

What were the payments for?

Payment categories

Category	Amount	Records
Food and Beverage	$140.77	2

A meal, consulting fee, royalty, and travel payment describe different kinds of reported relationships and should not be interpreted as equivalent.

Analysis 1 · Payment-linked products

Products named in Open Payments records

Reported product	Type	Reported company	Related amount*	Records	Year
NUCALA Normalized: nucala	Biological	GlaxoSmithKline, LLC.	$121.27	1	2025
Source payment records 2025-03-27 · GlaxoSmithKline, LLC. · $121.27 · Open Payments source
REXULTI Normalized: rexulti	Drug	Otsuka America Pharmaceutical, Inc.	$19.50	1	2025
Source payment records 2025-10-14 · Otsuka America Pharmaceutical, Inc. · $19.50 · Open Payments source

* Product-associated amounts are non-additive because one payment record may name more than one product.

These products were named on specific Open Payments records. A named product does not show that the payment influenced treatment or prescribing.

Public prescribing for products named in payments

Open Payments product	Payment year	Part D brand	Part D year	Claims	Match method	Source
REXULTI rexulti	2025	Rexulti	2024	21 Beneficiary count suppressed	exact normalized	Medicare Part D

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

Paying company	Payment year	Drug reported by same entity	Open Payments evidence	Part D	Claims	Beneficiaries
GlaxoSmithKline, LLC. Exact reporting entity; no affiliate inference	2025	AREXVY open payments reported associated product	CMS Open Payments — General Payments 47563 supporting records · 28786 recipient NPIs · example record 1190332445	Arexvy · 2024 Exact normalized brand match · 1 Part D row	24	24
GlaxoSmithKline, LLC. Exact reporting entity; no affiliate inference	2025	TRELEGY ELLIPTA open payments reported associated product	CMS Open Payments — General Payments 131532 supporting records · 37148 recipient NPIs · example record 1190332369	Trelegy Ellipta · 2024 Exact normalized brand match · 1 Part D row	28	11
Otsuka America Pharmaceutical, Inc. Exact reporting entity; no affiliate inference	2025	NUEDEXTA open payments reported associated product	CMS Open Payments — General Payments 393 supporting records · 285 recipient NPIs · example record 1227268901	Nuedexta · 2024 Exact normalized brand match · 1 Part D row	50	suppressed by CMS
Otsuka America Pharmaceutical, Inc. Exact reporting entity; no affiliate inference	2025	REXULTI open payments reported associated product	CMS Open Payments — General Payments 160756 supporting records · 46288 recipient NPIs · example record 1227267708	Rexulti · 2024 Exact normalized brand match · 1 Part D row	21	suppressed by CMS

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	2534	391
Sertraline Hcl	Sertraline Hcl	1540	164
Eliquis	Apixaban	1358	173
Levothyroxine Sodium	Levothyroxine Sodium	1329	190
Furosemide	Furosemide	1214	198
Pantoprazole Sodium	Pantoprazole Sodium	1056	211
Potassium Chloride	Potassium Chloride	1036	168
Gabapentin	Gabapentin	947	142
Metoprolol Tartrate	Metoprolol Tartrate	946	121
Amlodipine Besylate	Amlodipine Besylate	942	157
Trazodone Hcl	Trazodone Hcl	831	115
Lisinopril	Lisinopril	810	131
Tamsulosin Hcl	Tamsulosin Hcl	797	121
Divalproex Sodium	Divalproex Sodium	720	102
Memantine Hcl	Memantine Hcl	676	88
Metoprolol Succinate	Metoprolol Succinate	604	120
Metformin Hcl	Metformin Hcl	530	83
Donepezil Hcl	Donepezil Hcl	525	78
Mirtazapine	Mirtazapine	516	102
Carvedilol	Carvedilol	481	86
Losartan Potassium	Losartan Potassium	455	80
Omeprazole	Omeprazole	455	74
Clopidogrel	Clopidogrel Bisulfate	435	63
Levetiracetam	Levetiracetam	429	63
Duloxetine Hcl	Duloxetine Hcl	419	75
Spironolactone	Spironolactone	386	71
Escitalopram Oxalate	Escitalopram Oxalate	357	62
Famotidine	Famotidine	344	56
Buspirone Hcl	Buspirone Hcl	338	71
Baclofen	Baclofen	311	45
Torsemide	Torsemide	282	67
Citalopram Hbr	Citalopram Hydrobromide	263	36
Risperidone	Risperidone	261	35
Hydralazine Hcl	Hydralazine Hcl	257	52
Finasteride	Finasteride	243	29
Fluticasone Propionate	Fluticasone Propionate	243	87
Allopurinol	Allopurinol	239	39
Quetiapine Fumarate	Quetiapine Fumarate	238	53
Myrbetriq	Mirabegron	231	24
Midodrine Hcl	Midodrine Hcl	216	55
Prednisone	Prednisone	211	78
Venlafaxine Hcl Er	Venlafaxine Hcl	199	24
Xarelto	Rivaroxaban	198	28
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	193	60
Carbidopa-Levodopa	Carbidopa/Levodopa	189	32
Nifedipine Er	Nifedipine	186	29
Rosuvastatin Calcium	Rosuvastatin Calcium	185	31
Pravastatin Sodium	Pravastatin Sodium	180	23
Olanzapine	Olanzapine	179	27
Latanoprost	Latanoprost	176	44
Methocarbamol	Methocarbamol	173	59
Ipratropium-Albuterol	Ipratropium/Albuterol Sulfate	170	90
Januvia	Sitagliptin Phosphate	169	14
Alendronate Sodium	Alendronate Sodium	167	28
Doxycycline Hyclate	Doxycycline Hyclate	167	96
Ropinirole Hcl	Ropinirole Hcl	162	21
Ondansetron Hcl	Ondansetron Hcl	158	91
Tramadol Hcl	Tramadol Hcl	158	41
Ciprofloxacin Hcl	Ciprofloxacin Hcl	154	100
Basaglar Kwikpen U-100	Insulin Glargine,hum.Rec.Anlog	150	24
Lorazepam	Lorazepam	149	35
Tizanidine Hcl	Tizanidine Hcl	147	22
Lantus	Insulin Glargine,hum.Rec.Anlog	144	30
Hydrochlorothiazide	Hydrochlorothiazide	138	23
Propranolol Hcl	Propranolol Hcl	138	suppressed
Jardiance	Empagliflozin	135	22
Amiodarone Hcl	Amiodarone Hcl	134	31
Oxybutynin Chloride Er	Oxybutynin Chloride	134	22
Trulicity	Dulaglutide	134	20
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	132	23
Glipizide	Glipizide	132	14
Meloxicam	Meloxicam	130	23
Warfarin Sodium	Warfarin Sodium	124	12
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	119	75
Simvastatin	Simvastatin	119	29
Tradjenta	Linagliptin	119	15
Pramipexole Dihydrochloride	Pramipexole Di-Hcl	117	13
Fluoxetine Hcl	Fluoxetine Hcl	115	26
Lactulose	Lactulose	115	23
Autoshield Duo Pen Needle	Pen Needle,dual Safety,diabetc	113	31
Sulfamethoxazole-Trimethoprim	Sulfamethoxazole/Trimethoprim	112	46
Albuterol Sulfate Hfa	Albuterol Sulfate	111	67
Aripiprazole	Aripiprazole	111	18
Diclofenac Sodium	Diclofenac Sodium	108	40
Oxycodone Hcl	Oxycodone Hcl	106	34
Nitrofurantoin Mono-Macro	Nitrofurantoin Monohyd/M-Cryst	104	59
Atenolol	Atenolol	103	18
Pregabalin	Pregabalin	96	16
Nitrofurantoin	Nitrofurantoin Macrocrystal	94	15
Amitriptyline Hcl	Amitriptyline Hcl	93	18
Topiramate	Topiramate	92	suppressed
Novofine Autocover	Pen Needle, Diabetic, Safety	90	35
Entresto	Sacubitril/Valsartan	89	23
Ezetimibe	Ezetimibe	89	14
Montelukast Sodium	Montelukast Sodium	89	22
Dicyclomine Hcl	Dicyclomine Hcl	86	19
Hydroxychloroquine Sulfate	Hydroxychloroquine Sulfate	86	suppressed
Clonidine Hcl	Clonidine Hcl	85	25
Santyl	Collagenase Clostridium Hist.	83	24
Ceftriaxone	Ceftriaxone Sodium	82	56
Hydroxyzine Hcl	Hydroxyzine Hcl	81	28
Humalog Kwikpen U-100	Insulin Lispro	80	25
Cephalexin	Cephalexin	76	48
Clonazepam	Clonazepam	75	13
Levofloxacin	Levofloxacin	75	47
Lidocaine Hcl	Lidocaine Hcl	75	54
Ranolazine Er	Ranolazine	75	12
Memantine Hcl Er	Memantine Hcl	73	suppressed
Azithromycin	Azithromycin	72	53
Humalog	Insulin Lispro	71	14
Paroxetine Hcl	Paroxetine Hcl	71	suppressed
Xifaxan	Rifaximin	70	suppressed
Dropsafe Pen Needle	Pen Needle, Diabetic, Safety	69	22
Nuplazid	Pimavanserin Tartrate	69	suppressed
Sucralfate	Sucralfate	69	12
Isosorbide Mononitrate Er	Isosorbide Mononitrate	68	18
Metformin Hcl Er	Metformin Hcl	68	17
Trospium Chloride	Trospium Chloride	68	suppressed
Gemtesa	Vibegron	64	suppressed
Lamotrigine	Lamotrigine	64	14
Oxybutynin Chloride	Oxybutynin Chloride	64	13
Triamcinolone Acetonide	Triamcinolone Acetonide	64	17
Divalproex Sodium Er	Divalproex Sodium	63	13
Fluconazole	Fluconazole	63	30
Bupropion Hcl	Bupropion Hcl	62	suppressed
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	61	21
Levemir	Insulin Detemir	61	suppressed
Ondansetron Odt	Ondansetron	61	34
Benztropine Mesylate	Benztropine Mesylate	60	suppressed
Admelog Solostar	Insulin Lispro	59	16
Brimonidine Tartrate	Brimonidine Tartrate	59	11
Chlorhexidine Gluconate	Chlorhexidine Gluconate	57	15
Esomeprazole Magnesium	Esomeprazole Magnesium	57	suppressed
Sodium Chloride	0.9 % Sodium Chloride	57	32
Albuterol Sulfate	Albuterol Sulfate	56	29
Bupropion Hcl Sr	Bupropion Hcl	55	suppressed
Bupropion Xl	Bupropion Hcl	54	suppressed
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	54	suppressed
Nystatin	Nystatin	54	32
Meclizine Hcl	Meclizine Hcl	53	20
Mupirocin	Mupirocin	52	16
Valacyclovir	Valacyclovir Hcl	51	suppressed
Galantamine Hbr	Galantamine Hbr	50	16
Lithium Carbonate Er	Lithium Carbonate	50	suppressed
Nuedexta	Dextromethorphan Hbr/Quinidine	50	suppressed
Haloperidol	Haloperidol	49	suppressed
Breo Ellipta	Fluticasone/Vilanterol	48	14
Sevelamer Carbonate	Sevelamer Carbonate	48	13
Valsartan	Valsartan	47	14
Venlafaxine Hcl	Venlafaxine Hcl	47	suppressed
Phenytoin Sodium Extended	Phenytoin Sodium Extended	46	suppressed
Prednisolone Acetate	Prednisolone Acetate	46	15
Farxiga	Dapagliflozin Propanediol	45	suppressed
Metoclopramide Hcl	Metoclopramide Hcl	45	suppressed
Novolog Flexpen	Insulin Aspart	45	20
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	45	suppressed
Carbamazepine	Carbamazepine	44	suppressed
Digoxin	Digoxin	44	suppressed
Desvenlafaxine Succinate Er	Desvenlafaxine Succinate	43	suppressed
Doxepin Hcl	Doxepin Hcl	43	suppressed
Hydroxyzine Pamoate	Hydroxyzine Pamoate	43	13
Primidone	Primidone	43	suppressed
Labetalol Hcl	Labetalol Hcl	41	suppressed
Methotrexate	Methotrexate Sodium	41	suppressed
Sotalol	Sotalol Hcl	41	suppressed
Estradiol	Estradiol	40	11
Fenofibrate	Fenofibrate Nanocrystallized	40	suppressed
Insulin Lispro	Insulin Lispro	40	13
Ketoconazole	Ketoconazole	40	14
Lacosamide	Lacosamide	40	suppressed
Lithium Carbonate	Lithium Carbonate	40	suppressed
Methimazole	Methimazole	40	suppressed
Trimethoprim	Trimethoprim	40	suppressed
Creon	Lipase/Protease/Amylase	39	suppressed
Vitamin D2	Ergocalciferol (Vitamin D2)	39	suppressed
Benazepril Hcl	Benazepril Hcl	38	suppressed
Budesonide	Budesonide	38	suppressed
Doxazosin Mesylate	Doxazosin Mesylate	38	11
Leflunomide	Leflunomide	37	suppressed
Anastrozole	Anastrozole	36	suppressed
Clotrimazole-Betamethasone	Clotrimazole/Betamethasone Dip	36	18
Flecainide Acetate	Flecainide Acetate	36	suppressed
Ibuprofen	Ibuprofen	36	14
Butalbital-Acetaminophen-Caffe	Butalb/Acetaminophen/Caffeine	35	suppressed
Ipratropium Bromide	Ipratropium Bromide	35	11
Tresiba Flextouch U-100	Insulin Degludec	35	suppressed
Liothyronine Sodium	Liothyronine Sodium	34	suppressed
Metronidazole	Metronidazole	34	17
Rivastigmine	Rivastigmine	34	suppressed
Ziprasidone Hcl	Ziprasidone Hcl	34	suppressed
Rivastigmine	Rivastigmine Tartrate	33	suppressed
Galantamine Er	Galantamine Hbr	32	suppressed
Terazosin Hcl	Terazosin Hcl	32	suppressed
Fenofibrate	Fenofibrate,micronized	31	suppressed
Fludrocortisone Acetate	Fludrocortisone Acetate	31	suppressed
Gvoke Hypopen 2-Pack	Glucagon	31	suppressed
Glimepiride	Glimepiride	30	suppressed
Medroxyprogesterone Acetate	Medroxyprogesterone Acetate	30	suppressed
Vascepa	Icosapent Ethyl	30	suppressed
Hydrocortisone	Hydrocortisone	29	13
Nitroglycerin	Nitroglycerin	29	25
Cholestyramine	Cholestyramine (With Sugar)	28	suppressed
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	28	16
Quetiapine Fumarate Er	Quetiapine Fumarate	28	suppressed
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	28	11
Valproic Acid	Valproic Acid (As Sodium Salt)	28	suppressed
Atropine Sulfate	Atropine Sulfate	27	suppressed
Novolog	Insulin Aspart	27	13
Erythromycin	Erythromycin Base	26	17
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	26	18
Omega-3 Acid Ethyl Esters	Omega-3 Acid Ethyl Esters	26	suppressed
Sps	Sodium Polystyrene Sulfon/Sorb	26	17
Cefuroxime	Cefuroxime Axetil	25	17
Dorzolamide-Timolol	Dorzolamide Hcl/Timolol Maleat	25	suppressed
Incruse Ellipta	Umeclidinium Bromide	25	suppressed
Lovastatin	Lovastatin	25	suppressed
Abiraterone Acetate	Abiraterone Acetate	24	suppressed
Arexvy	Rsvpref3 Antigen/As01e/Pf	24	24
Calcium Acetate	Calcium Acetate	24	suppressed
Diltiazem 12hr Er	Diltiazem Hcl	24	suppressed
Diltiazem 24hr Er	Diltiazem Hcl	23	suppressed
Loperamide	Loperamide Hcl	23	17
Amoxicillin	Amoxicillin	22	19
Clozapine	Clozapine	22	suppressed
Insulin Lispro Kwikpen U-100	Insulin Lispro	22	suppressed
Metolazone	Metolazone	22	suppressed
Morphine Sulfate Er	Morphine Sulfate	22	suppressed
Pioglitazone Hcl	Pioglitazone Hcl	22	suppressed
Brilinta	Ticagrelor	21	suppressed
Diltiazem Hcl	Diltiazem Hcl	21	suppressed
Doxycycline Monohydrate	Doxycycline Monohydrate	21	suppressed
Humulin N	Insulin Nph Human Isophane	21	suppressed
Letrozole	Letrozole	21	suppressed
Nitroglycerin Patch	Nitroglycerin	21	suppressed
Paxlovid	Nirmatrelvir/Ritonavir	21	19
Rexulti	Brexpiprazole	21	suppressed
Cefdinir	Cefdinir	19	17
Restasis	Cyclosporine	19	suppressed
Timolol Maleate	Timolol Maleate	19	suppressed
Vancomycin Hcl	Vancomycin Hcl	19	suppressed
Exemestane	Exemestane	18	suppressed
Levalbuterol Hcl	Levalbuterol Hcl	18	suppressed
Linzess	Linaclotide	18	suppressed
Nystop	Nystatin	18	14
Ozempic	Semaglutide	18	suppressed
Fiasp	Insulin Aspart (Niacinamide)	17	suppressed
Fiasp Flextouch	Insulin Aspart (Niacinamide)	17	suppressed
Gemfibrozil	Gemfibrozil	17	suppressed
Megestrol Acetate	Megestrol Acetate	17	suppressed
Prazosin Hcl	Prazosin Hcl	17	suppressed
Amantadine	Amantadine Hcl	16	suppressed
Amlodipine Besylate-Benazepril	Amlodipine Besylate/Benazepril	16	suppressed
Clindamycin Hcl	Clindamycin Hcl	16	suppressed
Corlanor	Ivabradine Hcl	16	suppressed
Ingrezza	Valbenazine Tosylate	16	suppressed
Kapspargo Sprinkle	Metoprolol Succinate	16	suppressed
Lagevrio (Eua)	Molnupiravir	16	16
Methadone Hcl	Methadone Hcl	16	suppressed
Risedronate Sodium	Risedronate Sodium	16	suppressed
Trintellix	Vortioxetine Hydrobromide	16	suppressed
Bumetanide	Bumetanide	15	suppressed
Calcitriol	Calcitriol	15	suppressed
Combivent Respimat	Ipratropium/Albuterol Sulfate	15	suppressed
Dorzolamide Hcl	Dorzolamide Hcl	15	suppressed
Enoxaparin Sodium	Enoxaparin Sodium	15	suppressed
Fosfomycin Tromethamine	Fosfomycin Tromethamine	15	suppressed
Isosorbide Mononitrate	Isosorbide Mononitrate	15	suppressed
Ketorolac Tromethamine	Ketorolac Tromethamine	15	suppressed
Brimonidine Tartrate-Timolol	Brimonidine Tartrate/Timolol	14	suppressed
Gentamicin Sulfate	Gentamicin Sulfate	14	suppressed
Isosorbide Dinitrate	Isosorbide Dinitrate	14	suppressed
Linezolid	Linezolid	14	11
Loxapine	Loxapine Succinate	14	suppressed
Meropenem	Meropenem	14	suppressed
Wixela Inhub	Fluticasone Propion/Salmeterol	14	suppressed
Azelastine Hcl	Azelastine Hcl	13	suppressed
Clonidine	Clonidine	13	suppressed
Colestipol Hcl	Colestipol Hcl	13	suppressed
Diltiazem 24hr Er (Xr)	Diltiazem Hcl	13	suppressed
Enalapril Maleate	Enalapril Maleate	13	suppressed
Mesalamine	Mesalamine	13	suppressed
Verapamil Hcl	Verapamil Hcl	13	suppressed
Zolpidem Tartrate	Zolpidem Tartrate	13	suppressed
Anoro Ellipta	Umeclidinium Brm/Vilanterol Tr	12	suppressed
Balsalazide Disodium	Balsalazide Disodium	12	suppressed
Clobetasol Propionate	Clobetasol Propionate	12	suppressed
Etodolac	Etodolac	12	suppressed
Insulin Aspart	Insulin Aspart	12	suppressed
Irbesartan	Irbesartan	12	suppressed
Klayesta	Nystatin	12	suppressed
Methylprednisolone	Methylprednisolone	12	suppressed
Niacin Er	Niacin	12	suppressed
Promethazine Hcl	Promethazine Hcl	12	suppressed
Riluzole	Riluzole	12	suppressed
Toujeo Solostar	Insulin Glargine,hum.Rec.Anlog	12	suppressed
Breztri Aerosphere	Budesonide/Glycopyr/Formoterol	11	suppressed
Bromocriptine Mesylate	Bromocriptine Mesylate	11	suppressed
Dorzolamide-Timolol	Dorzolamide/Timolol/Pf	11	suppressed
Glipizide-Metformin	Glipizide/Metformin Hcl	11	suppressed
Humulin R	Insulin Regular, Human	11	suppressed
Insulin Glargine-Yfgn	Insulin Glargine-Yfgn	11	suppressed
Lumigan	Bimatoprost	11	suppressed
Moxifloxacin	Moxifloxacin Hcl	11	suppressed
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	11	suppressed
Silver Sulfadiazine	Silver Sulfadiazine	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	$140.77 · 2 records	GlaxoSmithKline, LLC.	NUCALA, REXULTI	4	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

What role, if any, does Rexulti play in your treatment recommendations for me?
How do you evaluate evidence when you have a financial relationship with GlaxoSmithKline, LLC.?
Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error